Administrative Core
行政核心
基本信息
- 批准号:8033334
- 负责人:
- 金额:$ 22.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimal ModelAreaArtsBiometryCenters of Research ExcellenceCerebrumChildClinicalCollaborationsCommunicationCommunitiesCongressesCore FacilityDevelopmental DisabilitiesEnsureEnvironmentFeedbackGeneticGoalsHealth Services AccessibilityHourHumanHuman ResourcesImageInformaticsInstitutionLeadershipMental RetardationMental Retardation and Developmental Disabilities Research CentersMethodsMissionModelingNeurosciences ResearchOutcomeProductivityProviderReportingResearchResearch ActivityResearch InfrastructureResearch PersonnelRoleScientistServicesUniversitiesWashingtonWorkbasecohesioncostexperiencemedical schoolsmeetingsmembernovelprofessorresearch facilityskillssuccesssymposiumweb site
项目摘要
Washington University in St. Louis is an internationally known neuroscience research institution. The WUIDDRC will build on this, making existing, sophisticated methods more readily accessible to Center investigators. The University also has fundamental gaps in its research infrastructure for intellectual and developmental disabilities, and the WUIDDRC will rectify those shortcomings. Finally, the WUIDDRC will promote a collaborative, interdisciplinary environment that will accelerate research productivity in intellectual
and developmental disabilities.
The primary objective of the Administrative Core is to support the Center's purpose and the attainment of these objectives by two key functions - scientific leadership and Administrative supportjo ensure excellence in Core services. The first and most important is the provision of scientific leadership facilitated by the spirited exchange of ideas. The second is the management, co-ordination and administration of all Center activities.
The core will support a range of leadership and Administrative functions including: 1) supporting the work of Core Directors; 2) managing the financial reporting; 3) assisting with staffing within Cores; 4) coordinating communication within the Center and with the community; 5) recruitment of new WUIDDRC investigative members; 6) managing the Center website; 7) coordinating research forums; and 8) disseminating research
information throughout the Center and the greater community. All investigators within the Center will have access to the services of the Administrative Core.
The scientific leadership of the Center is critical to the success of the mission of the Center. The Director, Dr. Terrie Inder, is responsible for steering the scientific course of the Center, making all budgetary decisions and coordinating WUIDDRC activities. The leadership of the Center was carefully thought through at the inception of the center. Dr. Inder was selected as the leader for the center based on the recognition of her strength as a researcher and leader by the senior members of the research community. She is dedicated to creating an environment of scientific excellence with support for facilities and personnel. She has developed strong working relationships with all the current Chairs and the Dean of the Medical School, who respect her skills and leadership. They have demonstrated their confidence in her by pledging nearly $2 million in support
over the first 5 years of the new center. Dr. Inder reports directly to the Dean of the Washington University School of Medicine in matters regarding the IDDRC. She was recently promoted to Full Professor at Washington University, effective July 1st '2010.
Following the first WUIDDRC submission. Dr. Inder elected to appoint a panel of Associate Directors to assist with the scientific direction of the Center and to provide broader experience in institutional leadership.
She selected each Associate Director primarily on the basis of his/her research and clinical expertise to fulfill a cleariy defined role in the leadership of the Center (Table A.I). This directorship model is functioning successfully in other Research Centers within Washington University, such as the Alzheimer's Disease Research Center. Each Associate Director has been assigned leadership areas related to his/her scientific
expertise. The Associate Directors review the short-term objectives and priorities of the Center with the Director via meetings or conference call for an hour every two weeks. All Associate Directors have invested in this commitment with regular meetings having commenced in December 2009. Issues to be covered at these meetings include co-ordination of seminars for the Center; challenges related to utilization and/or investigator
feedback for core services; budgetary issues; and community liaison. The long-term objectives and priorities will be reviewed every six months in conjunction with the Center Management Committee (CMC). These objectives include the scientific priorities of the WUIDDRC and their attainment. Items to be covered at these meetings include review of the research productivity of the Center; methods and success in attracting new
investigators; budgetary goals and outcomes; use of core services; feedback on quality from investigators; community liaison; and the integration of the WUIDDRC with other Center/Cores/Departmental services within Washington University.
圣路易斯华盛顿大学是国际知名的神经科学研究机构。 WUIDDRC 将以此为基础,使中心研究人员更容易使用现有的复杂方法。该大学在智力和发育障碍研究基础设施方面也存在根本性差距,WUIDDRC 将纠正这些缺陷。最后,WUIDDRC 将促进一个协作、跨学科的环境,从而提高知识分子领域的研究生产力。
和发育障碍。
行政核心的主要目标是通过两个关键职能(科学领导和行政支持)支持中心的宗旨和实现这些目标,以确保核心服务的卓越性。第一个也是最重要的是通过激烈的思想交流提供科学领导。第二个是中心所有活动的管理、协调和行政。
该核心将支持一系列领导和行政职能,包括: 1) 支持核心董事的工作; 2)管理财务报告; 3) 协助核心内部的人员配置; 4)协调中心内部以及与社区的沟通; 5) 招募新的WUIDDRC调查成员; 6)管理中心网站; 7)协调研究论坛; 8) 传播研究成果
整个中心和更大社区的信息。中心内的所有调查员都可以使用行政核心的服务。
该中心的科学领导对于中心使命的成功至关重要。主任 Terrie Inder 博士负责指导中心的科学进程、制定所有预算决策并协调 WUIDDRC 的活动。中心的领导层在成立之初就经过了深思熟虑。 Inder 博士被选为该中心的领导者是因为研究界的高级成员对她作为研究员和领导者的实力的认可。她致力于在设施和人员的支持下创造一个卓越的科学环境。她与医学院的所有现任主席和院长建立了牢固的工作关系,他们尊重她的技能和领导能力。他们承诺提供近 200 万美元的支持,表达了对她的信心
新中心成立的前 5 年。 Inder 博士直接向华盛顿大学医学院院长汇报有关 IDDRC 的事宜。她最近晋升为华盛顿大学正教授,于 2010 年 7 月 1 日生效。
继第一次 WUIDDRC 提交之后。 Inder 博士选择任命一个副主任小组来协助该中心的科学方向,并在机构领导方面提供更广泛的经验。
她主要根据他/她的研究和临床专业知识来选择每位副主任,以履行中心领导中明确定义的角色(表 A.I)。这种领导模式在华盛顿大学的其他研究中心(例如阿尔茨海默病研究中心)成功运作。每个副主任都被分配了与其科学相关的领导领域
专业知识。副主任通过每两周一小时的会议或电话会议与主任一起审查中心的短期目标和优先事项。所有副董事均已投入到这一承诺中,并于 2009 年 12 月开始召开定期会议。这些会议将讨论的问题包括协调中心的研讨会;与利用和/或研究者相关的挑战
核心服务的反馈;预算问题;和社区联络。长期目标和优先事项将与中心管理委员会(CMC)一起每六个月审查一次。这些目标包括 WUIDDRC 的科学优先事项及其实现情况。这些会议讨论的项目包括审查中心的研究生产力;吸引新人的方法和成功
调查员;预算目标和结果;使用核心服务;研究者对质量的反馈;社区联络; WUIDDRC 与华盛顿大学内其他中心/核心/部门服务的整合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERRIE E INDER其他文献
TERRIE E INDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERRIE E INDER', 18)}}的其他基金
Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants
漫相关光谱监测脑血流和检测极早产儿脑室内出血的开发和评估
- 批准号:
10403869 - 财政年份:2021
- 资助金额:
$ 22.26万 - 项目类别:
Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants
漫相关光谱监测脑血流和检测极早产儿脑室内出血的开发和评估
- 批准号:
10468687 - 财政年份:2021
- 资助金额:
$ 22.26万 - 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
- 批准号:
8018716 - 财政年份:2010
- 资助金额:
$ 22.26万 - 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
- 批准号:
8311712 - 财政年份:2010
- 资助金额:
$ 22.26万 - 项目类别:
Washington University Intellectual and Developmental Disabilities Research Center
华盛顿大学智力与发育障碍研究中心
- 批准号:
8118140 - 财政年份:2010
- 资助金额:
$ 22.26万 - 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
- 批准号:
8066229 - 财政年份:2010
- 资助金额:
$ 22.26万 - 项目类别:
UNDERSTANDING NEUROBEHAVIORAL DEFICITS IN PRETERM INFANTS THROUGH IMAGING
通过影像学了解早产儿的神经行为缺陷
- 批准号:
7935130 - 财政年份:2009
- 资助金额:
$ 22.26万 - 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
- 批准号:
7447715 - 财政年份:2008
- 资助金额:
$ 22.26万 - 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
- 批准号:
7647983 - 财政年份:2008
- 资助金额:
$ 22.26万 - 项目类别:
Neurobehavioral Impairments in Preterm Children - A Longitudinal MR Study
早产儿的神经行为损伤——一项纵向 MR 研究
- 批准号:
7796832 - 财政年份:2008
- 资助金额:
$ 22.26万 - 项目类别:
相似国自然基金
冠状动脉微血管疾病大动物模型中关键分子和心肌血流超声显像新技术研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
视神经脊髓炎谱系疾病非人灵长类动物模型构建及表型评价
- 批准号:82071341
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
mTOR信号通路在耳蜗毛细胞发育和存活中的调控作用及其机制研究
- 批准号:81900937
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
利用可视可控hypocretin神经元凋亡的疾病模型进行发作性睡病发病机制研究
- 批准号:81901346
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
相似海外基金
Role of microglial lysosomes in amyloid-A-beta degradation
小胶质细胞溶酶体在淀粉样蛋白-A-β降解中的作用
- 批准号:
10734289 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Dissemination of the Human Neocortical Neurosolver (HNN) software for circuit level interpretation of human MEG/EEG
传播用于人类 MEG/EEG 电路级解释的人类新皮质神经解算器 (HNN) 软件
- 批准号:
10726032 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Engineering a human neuroimmune specific viral vector from Zika virus
从寨卡病毒中工程化人类神经免疫特异性病毒载体
- 批准号:
10727590 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Neuronal Activity in Sleep & Wake in Alzheimer's Disease Mice
睡眠中的神经元活动
- 批准号:
10723302 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
NUP50 as a modifier and risk factor for TDP-43 pathology in FTD/ALS
NUP50 作为 FTD/ALS 中 TDP-43 病理的修饰剂和危险因素
- 批准号:
10800366 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别: